Cryo-Save Group N.V.: admission to aim with market capitalisation of £101.2M

November 1, 2007 Group News

Cryo-Save Group N.V. (“Cryo-Save”, “the Group” or “the Company”), Europe’s largest adult stem cell storage bank, is to be admitted to AIM with a market capitalisation of £101.17 million. The Group has raised £26.54 million, before expenses, via a placing of shares at 210p per share with institutional investors. Trading in Cryo-Save shares is expected to start on Tuesday 6 November 2007.

read more

Portuguese child successfully treated with private stored stem cells

July 16, 2007 Group News

Porto / Brussels July 16 2007. – A child suffering from a severe T-cell (CD8+) immune deficiency syndrome has been treated successfully with umbilical cord blood stem cells in Portugal. The child’s congenital dificiency was clinically diagnosed in Coimbra. The transplantation treatment was performed at the Bone Marrow Transplantation Unit, lead by director Dr. Pedro Pimentel at the Oncology Institute in Porto. Dr. Alzira Carvalhais is the head of the Immuno-Hemato Therapy Department.

read more